BIODESIX INC Share Price Today: Live Updates & Key Insights

BIODESIX INC share price today is $14.59, up -8.74%. The stock opened at $16.25 against the previous close of $16.3, with an intraday high of $16.3295 and low of $14.835.

BIODESIX INC Share Price Chart

BIODESIX INC

us-stock
To Invest in {{usstockname}}
us-stock

BIODESIX INC Share Price Performance

$14.59 -0.0874(-8.74%) BDSX at 23 Mar 2026 12:11 PM Diagnostics & Research
Lowest Today 14.835
Highest Today 16.3295
Today’s Open 16.25
Prev. Close 16.3
52 Week High 20.21
52 Week Low 3.44
Day’s Range: Low 14.835 High 16.3295
52-Week Range: Low 3.44 High 20.21
1 day return -
1 Week return -13.25
1 month return +17.38
3 month return +119.15
6 month return +108.77
1 year return +1734.53
3 year return +705.91
5 year return -28.34
10 year return -

BIODESIX INC Institutional Holdings

abrdn Healthcare Opportunities 3.44

Telemark Asset Management, LLC 3.33

Aberdeen Group PLC 2.66

Vanguard Total Stock Mkt Idx Inv 2.07

Vanguard Group Inc 1.95

Monashee Investment Management LLC 1.14

Perceptive Advisors LLC 1.10

GSA Capital Partners LLP 0.65

Perkins Capital Management Inc 0.45

Vanguard Institutional Extnd Mkt Idx Tr 0.44

Geode Capital Management, LLC 0.43

Balyasny Asset Management LLC 0.33

Trexquant Investment LP 0.28

Citadel Advisors Llc 0.26

BlackRock Inc 0.25

Fidelity Extended Market Index 0.22

Shay Capital LLC 0.16

State Street Corp 0.16

Cetera Investment Advisers 0.10

Royal Bank of Canada 0.09

Blackrock Extended Mkt Fund CF 0.08

NT Ext Equity Mkt Idx Fd - L 0.07

Fidelity Total Market Index 0.07

Extended Equity Market Fund K 0.07

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Vanguard Balanced Index Inv 0.06

Fidelity Series Total Market Index 0.05

Hanson Mcclain Inc 0.05

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Spartan Extended Market Index Pool F 0.03

Spartan Total Market Index Pool G 0.03

Fidelity Nasdaq Composite Index 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

Vanguard U.S. Eq Idx £ Acc 0.01

Tower Research Capital LLC 0.00

Quattro Advisors L.L.C. 0.00

Fortitude Family Office LLC 0.00

BIODESIX INC Market Status

Strong Buy: 4

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

BIODESIX INC Fundamentals

Market Cap 146.64 M

PB Ratio 44.5694

PE Ratio 0.0

Enterprise Value 214.56 M

Total Assets 87.48 M

Volume 91915

BIODESIX INC Company Financials

Annual Revenue FY23:44026000 44.0M, FY22:38212000 38.2M, FY21:54506000 54.5M, FY20:45557000 45.6M, FY19:24552000 24.6M

Annual Profit FY23:31084000 31.1M, FY22:24058000 24.1M, FY21:23988000 24.0M, FY20:23559000 23.6M, FY19:18478000 18.5M

Annual Net worth FY23:-63345000 -63.3M, FY22:-80388000 -80.4M, FY21:-44480000 -44.5M, FY20:-36473000 -36.5M, FY19:-31355000 -31.4M

Quarterly Revenue Q3/2025:21768000 21.8M, Q2/2025:20018000 20.0M, Q1/2025:17958000 18.0M, Q3/2024:18151000 18.2M, Q2/2024:17925000 17.9M

Quarterly Profit Q3/2025:17662000 17.7M, Q2/2025:15987000 16.0M, Q1/2025:14255000 14.3M, Q3/2024:13972000 14.0M, Q2/2024:14048000 14.0M

Quarterly Net worth Q3/2025:-8716000 -8.7M, Q2/2025:-11468000 -11.5M, Q1/2025:-11101000 -11.1M, Q3/2024:-10258000 -10.3M, Q2/2024:-10808000 -10.8M

About BIODESIX INC & investment objective

Company Information Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Organisation Diagnostics & Research

Employees 334

Industry Diagnostics & Research

CEO Mr. Scott Hutton

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BIODESIX INC FAQs

What is the share price of BIODESIX INC today?

The current share price of BIODESIX INC is $14.59.

Can I buy BIODESIX INC shares in India?

Yes, Indian investors can buy BIODESIX INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy BIODESIX INC shares in India?

You can easily invest in BIODESIX INC shares from India by:

Can I buy fractional shares of BIODESIX INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BIODESIX INC?

BIODESIX INC has a market cap of $146.64 M.

In which sector does BIODESIX INC belong?

BIODESIX INC operates in the Diagnostics & Research sector.

What documents are required to invest in BIODESIX INC stocks?

To invest, you typically need:

What is the PE and PB ratio of BIODESIX INC?

The PE ratio of BIODESIX INC is N/A and the PB ratio is 44.57.